Latest News
The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.39%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.21%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.54%. Stock indexes this morning recovered from early losses and are posting moderate gains....
The S&P 500 Index ($SPX ) (SPY ) this morning is down -0.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.26%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.14%. Stock indexes this morning are mixed. Higher bond yields are negative for stocks...
The Chart of the Day belongs to the building products and equipment company Carlisle Companies (CSL) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then...
Health Canada Authorizes CSL's HEMGENIX® (etranacogene dezaparvovec) as First Gene Therapy for Hemophilia B
/CNW/ -- Global biotechnology leader CSL (ASX: CSL) today announced that Health Canada has authorized HEMGENIX® (etranacogene dezaparvovec), the first and only...
New Data Presented at IDWeek 2023 Demonstrates Public Health Benefit and Cost Savings Associated with Cell-Based and Adjuvanted Influenza Vaccines
Data evaluating the impact of cell-based quadrivalent influenza vaccines suggests an additional 31%–39% of influenza cases may have been prevented among...
CSL Seqirus Presents Real-World Evidence at ESWI Demonstrating the Impact of Influenza Vaccination Campaigns to Help Protect People and Healthcare Systems
Results from a retrospective cohort study from 2015 to 2020 demonstrated a notable rise with increasing age in pneumonia-related medical encounters following...
CSL Seqirus Announces Third U.S. Government Award in Relation to Influenza A(H5N8) Candidate Vaccine
/PRNewswire/ -- CSL Seqirus, a business of CSL (ASX: CSL), was selected by the Biomedical Advanced Research and Development Authority (BARDA), part of the...
CSL Appoints Jeffrey Ball as First Chief Sustainability Officer
/PRNewswire/ -- Global biotechnology leader CSL (ASX: CSL) (USOTC: CSLLY) announced today that Jeffrey Ball, an established global leader across multiple...
CSL Seqirus Begins Shipping Portfolio of Innovative Influenza Vaccines for the 2023/24 U.S. Season
CSL Seqirus is the only influenza vaccine manufacturer that offers differentiated vaccine options for individuals six months of age and older. Since the...
4 Industrial Stocks That Are Screaming Buys in June
These vital manufacturers could produce stellar returns.
Carlisle Companies Declares Regular Quarterly Dividend
Carlisle Companies Incorporated (NYSE:CSL) has declared a dividend of $0.75 per share, payable on June 1, 2023, to shareholders of record at the close of business on May 17, 2023.
Carlisle Companies Elects C. David Myers to its Board of Directors
Carlisle Companies Incorporated (NYSE:CSL) announced today that C. David Myers has been elected to its Board of Directors effective immediately.
Carlisle Companies Announces May 2023 Events with the Financial Community
Carlisle Companies Incorporated (NYSE:CSL) today announced participation in the following upcoming events with the financial community in the month of May:
Carlisle Companies Reports First Quarter Results
Carlisle Companies Incorporated (NYSE:CSL) today announced its first quarter 2023 financial results.
3 Stocks You Can Keep Forever
Three solid profitable companies that are growing their businesses and their dividends.
Carlisle Companies to Announce First Quarter 2023 Results on April 27, 2023
Carlisle Companies Incorporated (NYSE:CSL) will release first quarter 2023 results on Thursday, April 27, 2023, after the market close. A conference call to discuss these results has been scheduled for 5pm ET on Thursday, April 27, 2023. The call...
Carlisle Companies Announces March 2023 Events with the Financial Community
Carlisle Companies Incorporated (NYSE:CSL), today announced participation in the following upcoming events with the financial community in the month of March:
Dividend kings are a popular choice for income investors. Here are some upcoming dividend kings you can consider adding to your portfolio.
First Gene Therapy for Hemophilia B, CSL's HEMGENIX®, Approved by the European Commission
/PRNewswire/ -- Global biotechnology leader CSL (ASX: CSL) today announced that the European Commission has granted conditional marketing authorization (CMA)...
Carlisle Companies Reports Record Fourth Quarter and Full Year 2022 Results
Carlisle Companies Incorporated (NYSE:CSL) today announced its fourth quarter 2022 financial results.
Carlisle Companies Declares Regular Quarterly Dividend
The Board of Directors of Carlisle Companies Incorporated (NYSE:CSL) has declared a dividend of $0.75 per share, payable on March 1, 2023, to shareholders of record at the close of business on February 17, 2023.
Carlisle Companies to Announce Fourth Quarter 2022 Results on February 7, 2023
Carlisle Companies Incorporated (NYSE:CSL) will release fourth quarter 2022 results on Tuesday, February 7, 2023, after the market close. A conference call to discuss these results has been scheduled for 5pm ET on Tuesday, February 7, 2023. The...
Carlisle Companies Announces Commitment to Achieve Net-Zero GHG Emissions by 2050
Carlisle Companies Incorporated (NYSE:CSL) today announced a commitment to achieve Net-Zero greenhouse gas emissions across its entire value chain by 2050. Carlisle has proposed near-term greenhouse gas reduction targets through the Science Based...
CSL's Novel Gene Therapy HEMGENIX® (etranacogene dezaparvovec-drlb) Demonstrates Durable Protection and Sustained Factor IX Activity Levels for People Living with Hemophilia B at 24-Months Post-Treatment
/PRNewswire/ -- Global biotechnology leader CSL (ASX: CSL) today announced the presentation of data affirming the long-term durability and safety of...
FDA approval of costly--but worthwhile--drug leads the momentum that could make CSL Ltd an equally worthwhile investment.